Ensign Group has delivered a strong run over the past few years, and the share price now reflects a lot of optimism. The live question is whether that price is in line with the cash flows the business is expected to generate.
-
Over the last 5 years the stock has returned 143.3%, which puts real weight on whether those gains are backed by the underlying cash flow stream.
-
The group runs a cash generative post-acute care model, so the value investors place on the shares may hinge on how efficiently earnings are converted into cash and reinvested in new facilities.
-
If you'd rather focus on earnings, this one's for you. See what Ensign Group's 27.0x P/E says about the price .
The stock's next move may depend on whether Ensign Group's current share price fairly reflects the value of its future cash flows.
If you are weighing Ensign Group through the lens of its cash flows, it can help to compare it with other businesses in our 30 high quality undervalued stocks
Where Does Ensign Group Sit on Cash Flow?
The Discounted Cash Flow (DCF) model here is built around the cash that Ensign Group can return to shareholders over time. On the latest figures, the business generated trailing free cash flow of about $515.9 million, which gives the model a solid current cash base rather than a purely theoretical forecast.
Analysts then project free cash flow in the $400 million range by 2028, with the longer term assumptions pointing to relatively steady rather than explosive expansion in dollar cash flows. When those projected streams are discounted back and compared with today's share price of $186.32, the DCF output places Ensign Group's estimated intrinsic value broadly in line with where the market is trading, which suggests expectations for the business are already well reflected in the quote. Find out what Ensign Group could be worth using our Discounted Cash Flow (DCF) estimate .
The Ensign Group Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Ensign Group pick up where the cash flow puzzle leaves off. They spell out which paths for Ensign Group's growth, margins and earnings would need to play out for the stock to be worth meaningfully more or materially less than today. Each narrative connects its number to a clear view on how growth, profitability and risk could evolve. You can revisit these narratives as fresh information comes through.
One of the top community narratives on Ensign Group: 15% undervalued
"Ageing demographics and growing post acute care needs are supporting higher patient volumes, which can sustain occupancy and skilled mix levels across Ensign Group facilities…"
Discover why this Narrative puts Ensign Group at 15% undervalued .
One more Ensign Group check that belongs beside the cash flow math
Price and cash generation tell only part of the Ensign Group story, because the people steering the business and the way their pay is structured can heavily influence what happens next. See who runs Ensign Group and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENSG .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
